Paris Cedex 18

• Randomized open-label controlled trial evaluating a single-dose intravenous Dalbavancin versus standard antibiotic therapy during catheterre … Recruiting
  2024-514952-34-00 5 2023-06-23 Catheter related bloodstream infections due to Staphylococcus aureus
• RIISC Recruiting
  2024-513669-38-00 5 2023-05-17 Stroke, Ischemic, TIA, Cardiac Disease, Atherosclerosis, Myocardial In
• Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis (TEDITUB) Recruiting
  2024-512759-19-00 4 2023-04-20 first suspected infection with Mycobacterium tuberculosis in the lungs
• THINK - intensification of blood pressure lowering Therapeutics based on diuretics versus usual management for uncontrolled Hypertension IN … Recruiting
  2022-501494-39-00 5 2023-03-28 Uncontrolled Hypertension IN patients with moderate to severe chronic
• EvER-ILD 2: Evaluation of Efficacy and safety of Rituximab in patients with progressive Interstitial Lung Disease (ILD) with inflammatory co … Recruiting
  2022-501335-16-00 10 2023-01-16 Interstitial lung disease
• Early discontinuation of steroid treatment in negative FDG-PET/CT patients with idiopathic retroperitoneal fibrosis Recruiting
  2024-514353-30-00 6 2022-11-25 Idiopathic retroperitoneal fibrosis
• ASPIC - Antimicrobial Stewardship for Ventilator Associated Pneumonia in Intensive Care Recruiting
  2024-513327-16-00 5 2022-09-20 Intensive care
• VAC-WARTS Recruiting
  2024-513671-40-00 5 2022-06-29 HPV vaccine
• FI-3, Fidelia Recruiting
  2024-518243-38-00 5 2022-04-20 Fecal incontinence in female and male patients
• Selatogrel Outcome Study in Suspected Acute Myocardial Infarction Recruiting
  2023-505438-85-00 5 2022-01-12 Acute myocardial infarction (AMI)
• Predictive Signature of Benralizumab Response. BENRAPRED Study. Recruiting
  2024-514843-27-00 6 2021-10-11 Severe asthma
• Short Treatment With Omalizumab for Severe Asthma (SHORTEN) Recruiting
  2024-513427-17-00 6 2021-05-20 Well controlled severe allergic asthma
• A multicenter, prospective, randomized, placebo-controlled, double-blind, multi-arm, multi-stage clinical trial of Ivabradine for heart Rate … Recruiting
  2024-515019-22-00 5 2021-02-26 Septic shock
• INTOReTAK - Multicentre, randomized, prospective trial evaluating the efficacy and safety of Infliximab to tocilizumab in refractory or rela … Recruiting
  2024-512229-10-00 4 2021-02-04 Takayasu arteritis
• Study comparing a metformin treatment to standard care to extend time without diabetes after bariatric surgery Recruiting
  2024-516409-22-00 5 2021-01-07 Type 2 Diabetes complete remission after bariatric surgery under antid
• Clinical trial to evaluate safety and effectiveness of APL-101 for the treatment of advanced MET expressing solid tumors, including Non-Smal … Recruiting
  2024-514542-37-00 9 2020-08-13 Select advanced solid tumors and Non-Small Cell Lung Cancer with MET a
• Evaluation of efficacy and tolerance of fludrocortisone (Flucortac) in the treatment of neurogenic orthostatic hypotension Recruiting
  2024-517841-16-00 6 2020-07-09 Neurogenic Orthostatic Hypotension
• Prospective multicenter randomized double-blind study comparing caspofungin to placebo for the treatment of ICU yeast intra-abdominal infect … Recruiting
  2024-516266-11-00 5 2020-01-06 yeast intra-abdominal infection, peritonitis
• CLAZI : CLArithromycin versus AZIthromycin in the treatment of Mycobacterium avium complex pulmonary infections: A randomized prospective co … Recruiting
  2024-518578-15-00 5 2018-02-05 Is to demonstrate a non inferior efficacy of azithromycin and so the p
• A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons with HIV-1 (INNOVATE Study) Ended recruitment
  2025-521918-26-00 4 2026-02-11 HIV Infections
• A clinical study of MK-8527 to prevent HIV-1 (MK-8527-011) Ended recruitment
  2025-520610-58-00 5 2025-11-19 HIV-1 prevention
• Phase 2b Clinical Study Evaluating Efficacy and Safety of TAR-200 in Combination with Cetrelimab, TAR-200 Alone, or Cetrelimab Alone in Part … Ended recruitment
  2023-506146-23-00 4 2025-11-17 Non-Muscle-Invasive Urothelial Carcinoma (NMIBC) of the Bladder
• APOLLO: A Randomized, Double-Blind, Placebo-Controlled Study of Bitopertin to Evaluate the Efficacy, Safety, and Tolerability in Participant … Ended recruitment
  2024-520407-27-00 5 2025-10-23 X-Linked Protoporphyria (XLP)
• Impact of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis persistence and coverage in men who have sex with men in Fran … Ended recruitment
  2024-510678-25-00 11 2025-05-14 HIV prevention

Showing 121–144 of 258 trials